We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$9.63B
1-Year Est. Return
30.32%
This Fund
S&P 500
This Quarter
Est. Return
-12.62%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.04B
AUM Growth
-$478M
(-11%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
17.02%
Holding
1,665
New
527
Increased
388
Reduced
715
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$39.2M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$36.8M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$26.2M |
| 4 |
Citigroup
C
|
+$25.2M |
| 5 |
Magna International
MGA
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$16.9M |
| 2 |
PX
Praxair Inc
PX
|
+$4.85M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$4.81M |
| 4 |
Clean Harbors
CLH
|
+$4.7M |
| 5 |
Patterson-UTI
PTEN
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Financials | 13.52% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 9.07% |
| 5 | Consumer Discretionary | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Thermo Fisher Scientific
TMO
$220B
| $9.63M | 0.24% |
43,053
-2,483
| -5% | -$583K |
|
102
American Tower
AMT
$80.4B
| $9.26M | 0.23% |
58,547
+6,685
| +13% | +$1.05M |
|
103
Becton Dickinson
BDX
$48.7B
| $9.21M | 0.23% |
41,880
+1,193
| +3% | +$277K |
|
104
Meta Platforms (Facebook)
META
$1.51T
| $8.94M | 0.22% |
68,171
-5,243
| -7% | -$760K |
|
105
Ecolab
ECL
$79.9B
| $8.93M | 0.22% |
60,575
-209
| -0.3% | -$31.9K |
|
|
FDC
106
DELISTED
First Data Corporation
FDC
| $8.72M | 0.22% |
515,704
+197,550
| +62% | +$3.85M |
|
107
Vertex Pharmaceuticals
VRTX
$126B
| $8.72M | 0.22% |
52,612
-1,581
| -3% | -$274K |
|
108
Accenture
ACN
$108B
| $8.67M | 0.21% |
61,475
-2,744
| -4% | -$434K |
|
|
ANSS
109
DELISTED
Ansys
ANSS
| $8.63M | 0.21% |
60,389
+18,315
| +44% | +$2.85M |
|
110
Amgen
AMGN
$222B
| $8.53M | 0.21% |
43,791
+3,150
| +8% | +$615K |
|
111
Lowe's Companies
LOW
$125B
| $8.44M | 0.21% |
91,413
+18,334
| +25% | +$1.77M |
|
112
SAP
SAP
$238B
| $8.38M | 0.21% |
84,214
+573
| +0.7% | +$61K |
|
113
GSK
GSK
$106B
| $8.37M | 0.21% |
175,286
-17,082
| -9% | -$841K |
|
114
AbbVie
ABBV
$435B
| $8.18M | 0.2% |
88,708
-3,998
| -4% | -$352K |
|
115
FedEx
FDX
$75.4B
| $8.01M | 0.2% |
49,637
-5,347
| -10% | -$1.13M |
|
116
Linde
LIN
$226B
| $8M | 0.2% |
+51,244
| New | +$8.1M |
|
117
AstraZeneca
AZN
$250B
| $7.92M | 0.2% |
104,238
-8,498
| -8% | -$664K |
|
118
Alibaba
BABA
$308B
| $7.9M | 0.2% |
57,633
+690
| +1% | +$102K |
|
|
ULTI
119
DELISTED
Ultimate Software Group Inc
ULTI
| $7.85M | 0.19% |
32,053
+230
| +0.7% | +$61K |
|
120
Tapestry
TPR
$32.8B
| $7.76M | 0.19% |
229,825
-24,389
| -10% | -$982K |
|
121
RTX Corp
RTX
$301B
| $7.65M | 0.19% |
114,220
-19,062
| -14% | -$1.5M |
|
122
Oracle
ORCL
$423B
| $7.62M | 0.19% |
168,787
-13,272
| -7% | -$636K |
|
123
Canadian National Railway
CNI
$76.6B
| $7.61M | 0.19% |
102,688
-3,825
| -4% | -$317K |
|
124
Knight Transportation
KNX
$11.4B
| $7.6M | 0.19% |
303,043
-10,487
| -3% | -$325K |
|
125
Air Products & Chemicals
APD
$67.6B
| $7.59M | 0.19% |
47,451
+529
| +1% | +$83.8K |
|
Similar funds
TIM
SC
TCA
CCMT
LAMI
BAMF
DCP
HL
Oppenheimer Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Oppenheimer Asset Management held 1,665 positions worth $4.04B, down 11% from $4.51B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Oppenheimer Asset Management deployed $175M of net new capital in Q4 2018, opening 527 new positions and adding to 388 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 815,772 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was MetLife, an estimated $16.9M trimmed.
- Oppenheimer Asset Management's largest Q4 2018 buy was Vanguard FTSE All-World ex-US ETF: 815,772 shares worth $37.2M.
- Oppenheimer Asset Management added most to iShares Russell 1000 Value ETF in Q4 2018, an estimated $36.8M increase.
- Oppenheimer Asset Management's biggest Q4 2018 reduction was MetLife, cutting an estimated $16.9M.
- Oppenheimer Asset Management fully exited Praxair Inc in Q4 2018, selling an estimated $4.85M.
- Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.04B portfolio in Q4 2018.
- Oppenheimer Asset Management opened 527 new positions and closed 35 in Q4 2018.
- Oppenheimer Asset Management's portfolio value fell 11% quarter-over-quarter to $4.04B.
Based on Oppenheimer Asset Management's 13F filing for Q4 2018, filed 30 Jan 2019.